Summary.-Leucocyte migration inhibition by autologous breast tumour cell fractions was mediated by a soluble factor synthesized and released by mononuclear leucocytes and active against migrating granulocytes. This mechanism is similar to that previously described in respect to cell-mediated sensitivity to microbial antigens. Alternative mechanisms involving directly reactive granulocytes or cytophilic antibodies were rarely operative in the migration tests.
Summary.-Leucocyte migration inhibition by autologous breast tumour cell fractions was mediated by a soluble factor synthesized and released by mononuclear leucocytes and active against migrating granulocytes. This mechanism is similar to that previously described in respect to cell-mediated sensitivity to microbial antigens. Alternative mechanisms involving directly reactive granulocytes or cytophilic antibodies were rarely operative in the migration tests.
THE leucocyte migration test (LMT) of S0borg and Bendixen (1967) has been successfully employed in studies of tumour-directedimmuneresponses inpatients with breast cancer (Andersen et al., 1970; Cochran et al., 1974; Turnbull, 1974, 1975; McCoy et al., 1974) ; malignant melanoma (Cochran, Jehn and Gothoskar, 1972; McCoy et al., 1975) ; hypernephroma (Kjaer, 1974) ; and various other tumours (Wolberg, 1971; Segall et al., 1972) . Significant discrimination between patients and controls was achieved, and the possibility exists that this simple and reproducible assay might be of considerable value in the clinical assessment of patients with cancer.
Mechanisms involved in LMT have mainly been studied in respect of sensitization by bacterial, fungal and viral antigens, and it was thought that in most cases inhibition was mediated by a soluble factor (leucocyte inhibitory factor, LIF) released by sensitized lymphocytes in the presence of specific antigen (S0borg, 1969; Clausen, 1973; Rocklin, 1974; Hoffman et al., 1975) . Alternative mechanisms thought to be operative under certain circumstances included reactions between antigens and cytophilic antibodies on the surface of leucocytes (Packalen and Wasserman, 1971; Rocklin, 1974) and the direct action of antigen on sensitized granulocytes (Senyk and Hadley, 1973 Preparation of tumour cell fractions.-The preparation of particulate extracts from malignant breast tumours has been fully described elsewhere (Jones and Turnbull, 1975) . Briefly, tissue obtained at operation was minced and disrupted using a douncetype hand homogenizer and the homogenate centrifuged at 1000 g to remove nuclei. The supernatant (extract) was also further centrifuged at 3000 g and the sediment (3000 g fraction) retained. * Current address: K.R.U.F. Institute of Renal Disease, Royal Infirmary, Newport Road, Cardiff Separation of leucocytes -25-ml samples of blood were taken into 20 units/ml preservative-free heparin. 6-ml aliquots were layered on to 4 ml Ficoll-Triosil (FT), sp. gr. 1 07-1 08, and erythrocytes allowed to sediment for 60 min at room temperature. The upper layer of leucocyte-rich plasma was centrifuged at 350 g for 5 min and the cell pellet washed 3 times in tissue culture medium TC 199 supplemented with 13 mM NaHCO3, 20 mM HEPES buffer, 200 ,ug/ml L-glutamine, 300 i.u./ml penicillin and 300 ,ug/ml streptomycin.
To separate mononuclear leucocytes and granulocytes, leucocyte-rich plasmas were diluted with an equal volume of TC 199, layered on to further aliquots of FT and centrifuged at 400 g for 40 min. The white band of cells at the plasma-FT interface (mononuclears) and the cell pellet (granulocytes) were collected and washed 3 times in TC 199.
Cell migration tests.-Migration inhibition tests were performed using a semi-micro method developed specifically to utilize minimal quantities of tumour cell fractions and which was previously shown to give a high degree of reproducibility (Jones and Turnbull, 1975) . Tumour extracts at 100 and 200 jg/ml in TC 199 + 10% foetal calf serum (FCS), tumour 3000 g fraction at 100 and 200 Hg/ml, and control medium TC 199 + 10 % FCS without antigen were added to consecutive wells of the Sterilin migration chamber. Three heat-sealed capillaries, each containing 6 x 105 cells, were carefully positioned within each well, coverslips added and migration allowed to proceed for 18 h at 37°C. Migration areas were measured by projection microscopy and planimetry and migration indices (MI) for each dilution of antigen calculated as follows:
Mean migration area in MI-=tumour cell fraction -Mean migration area in control medium In a small number of cases, the effect of puromycin on leucocyte migration inhibition was examined, when protein synthesis inhibitor was included in the migration medium at a concentration of 10 jug/ml.
Indirect assay for LIF.-Mononuclear leucocytes from control subjects or from patients with breast cancer, 2 x 106/ml, were incubated for 3 days at 37°C in the presence 2 of 200 ,ug/ml tumour extract or 3000 g fraction, or in control medium TC 199 + 100% FCS, the culture volume being 0-8 ml. Culture supernatants were obtained by centrifugation at 1000 g for 10 min, and granulocytes from control subjects without breast cancer were used as migrating indicator cells for LIF produced during culture.
Cytophilic antibodies.-The presence of humoral factors able to passively sensitize control leucocytes was examined using the method of Amos et al. (1967) . Plasmas were obtained in the course of isolating leucocytes from whole blood; 20 samples came from breast cancer patients who had given positive results in direct LMTs against autologous tumour fractions, while 6 were from control subjects. Thrice washed leucocytes or separated granulocytes were incubated for 1 h at room temperature in 4 ml TC 199 + 10% plasma. Cells were recovered by centrifugation, carefully washed 3 times in TC 199 and dispensed into capillaries for migration tests against tumour extracts and 3000 g fractions.
RESULTS

Separated cell populations
Microscopic examination of JennerGiemsa-stained smears revealed that mononuclear cell preparations contained 87-95 (mean 89) Qo lymphocytes, 3-12 (mean 10) 00 monocytes and 0-3 (mean 1) % granulocytes. Granulocyte preparations contained 0-5 (mean 2.5) 00 contaminating lymphocytes.
Control MI values
In migration studies employing leucocytes from 58 control subjects and fractions from over 100 Table II , 7/10 breast cancer patients gave leucocyte migration inhibition by autologous extract and/or 3000g fraction in the absence of puromycin, while only 1/10 patients remained reactive in the presence of this agent (P < 0.05, X2 with Yates' correction). Comparison of leucocyte and granulocyte migration inhibition Leucocytes and separated granulocytes from 5 control subjects were used as migrating cells in tests against extracts and 3000 g fractions from 10 tumours. The mean MI for leucocytes was 0-98, range 0-84-1-13, while for granulocytes the mean was 0-95, range 0-84-1-16. Results shown in Table III indicated that although granulocytes from breast cancer patients were contaminated by up to 5% lymphocytes, migration was not inhibited in any of the tests against autologous breast tumour cell fractions. This was in contrast to the finding that leucocytes from the same patients were inhibited by autologous extract and/or 3000 g fraction in 5/10 cases (P < 0-05, x2 with Yates' correction). In view of the possibility that granulocyte response to LIF produced by contaminating lymphocytes, or the direct response of sensitized granulocytes to antigen, might be impaired due to additional cell separation procedures, isolated mononuclears and granulocytes were admixed to contain (Table III) .
Cytophilic antibodies
When control leucocytes or granulocytes were incubated with plasmas from healthy individuals before performing migration tests against breast tumour extracts and 3000 g fractions, MI values were within the normal range in all cases (0583-1b01, mean 0-91, for leucocytes; 0589-1b09, mean 0 99, for granulocytes). The migration of control leucocytes was inhibited after incubation with plasmas from only 4/20 LMT+ breast cancer patients, and although 2/20 plasmas caused enhanced migration of granulocytes, inhibition of these cells was not observed (Table IV) .
DISCUSSION
Leucocyte migration inhibition by breast tumour cell fractions was apparently not mediated by directly reactive granulocytes, nor in the majority of cases were cytophilic antibodies involved in the in vitro response. Addition of puromycin to LMTs suppressed inhibition, suggesting that active protein synthesis occurred in the course of the response to antigen. Mononuclear leucocytes, the majority of which were lymphocytes, from many of the patients studied, released a soluble factor into the culture medium when incubated with autologous tumour fractions, and this factor was able to inhibit the migration of granulocytes from control subjects without breast cancer. Thus the primary mechanism of leucocyte migration inhibition by insoluble tumour cell fractions was thought to be similar to that previously described in studies of delayed hypersensitivity to soluble microbial antigens.
While lymphokine production is thought to be a manifestation of the cellular immune system, production of macrophage inhibitory factor (Rocklin et al., 1974) , chemotactic factor (Altman and Mackler, 1974) and interferon (Epstein, Kreth and Herzenberg, 1974) by B-as well as T-lymphocytes has recently been reported. Fimmel (1975) showed that E rosette-forming cells were required for the production of LIF in response to E. coli somatic antigen, PPD and influenza virus antigen, but further studies are clearly required to determine the lymphocyte subpopulation active in leuco-cyte migration inhibition by particulate tumour-derived antigens.
We (Jones and Turnbull, 1975) . McCoy et al. (1974) have improved still further on our rate of approximately 5000 patients positive at 7 days after simple mastectomy: using 3M KCI extracts of breast tumours, significant leucocyte migration inhibition was obtained in 20/26 (770o) pre-or immediately postsurgery breast cancer patients. Possibly the higher rate of positives was due to the fact that soluble antigens could be used at higher concentrations without causing non-specific inhibition of control leucocyte migration.
It was previously shown that serial postoperative measurements of tumourdirected leucocyte migration inhibition in breast cancer patients may be of relevance to the understanding of the complex host-tumour interrelationship and may provide information of clinical significance (Jones and Turnbull, 1975; Jones et al., 1976) . This paper has tried to confirm that the in vitro response to particulate tumour-derived antigenic material is mediated by cellular immune mechanisms and thus permit interpretation of the clinical correlations observed in breast cancer patients. 
